在SHP2中致病性T42A突变重新连接其N端调节域的相互作用特异性
Anne E van Vlimmeren1,2, Rashmi Voleti1, Cassandra A Chartier1
1Department of Chemistry, Columbia University, New York, NY 10027.
bioRxiv : the preprint server for biology
|July 28, 2023
概括
与疾病相关的SHP2 SH2域突变可以改变蛋白质信号. T42A突变独特地改变了SHP2的联体特异性,影响了下游的信号通路.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- 氨酸酸酶SHP2的突变与各种人类疾病有关.
- 大多数与疾病相关的SHP2突变通过破坏自身抑制相互作用来增加其催化活性.
- 一些SHP2域中的SHP2突变不会增加基底活性,这表明了其他致病机制.
研究的目的:
- 了解SHP2 SH2域突变如何影响蛋白质结构,活性和信号传递.
- 为了描述五个SHP2 SH2域带结合的口袋突变物.
主要方法:
- 高通量生物化学屏幕的使用
- 生物物理和生物化学测量
- 分子动力学模拟的模拟.
主要成果:
- 一些SHP2 SH2域突变改变了对酸化位的结合亲和力.
- 在N-SH2域中的T42A突变独特地改变了联结特异性.
- 这种特异性变化是通过重塑色胺结合口袋来实现的,改变了连接体的参与.
- 突变T42A对激活连接体具有偏差敏感性,增强了下游信号传输.
结论:
- 与疾病相关的SHP2突变可以通过涉及改变蛋白质-蛋白质相互作用特异性的细微机制发挥作用.
- T42A突变提供了一个示例,说明SHP2连接体特异性的变化如何导致酶激活和下游信号的改变.
- 了解这些机制对于破译SHP2在人类疾病中的作用至关重要.
相关概念视频
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Translesion DNA Polymerases
10.0K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
10.0K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K


